Pregabalin NDC 82968-006

NDC codes

FDA NDC Directory

Product NDC (as listed)82968-006Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82968-0006Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82968-006-01	82968000601	90 CAPSULE in 1 BOTTLE (82968-006-01)Marketed from Feb 24, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pregabalin
Generic name (nonproprietary): pregabalin
Active ingredients: Pregabalin — 25 mg/1
Dosage form: Capsule
Route: Oral
Labeler: FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218529
Marketing start: Feb 24, 2026
Listing expires: Dec 31, 2027
DEA schedule: CV
Identifiers: Product ID 82968-006_4c41b54b-827a-1d04-e063-6394a90a55eaSPL ID 4c41b54b-827a-1d04-e063-6394a90a55eaSPL set ID 9bdea600-b561-4049-aa1c-3867b62fc1d3RxCUI 483438, 483440, 483442, 483444, 483446, 483448, 483450, 577127UNII 55JG375S6MUPC 0382968006011, 0382968013019, 0382968009029, 0382968008022, 0382968010018

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482968000601 followed by a unit qualifier and the quantity

Package 82968-0006-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 5, 2026.

Indications (excerpt from the label)

Pregabalin capsules are indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pregabalin capsules are indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 ) Postherpetic neuralgia (PHN) ( 1 ) Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older ( 1 ) Fibromyalgia ( 1 ) Neuropathic pain associated with spinal cord injury ( 1 )…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218529

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218529
Product	Strength	Form · route	Labeler	Product NDC
Pregabalin	Pregabalin 50 mg/1	CapsuleOral	FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED	82968-007
Pregabalin	Pregabalin 200 mg/1	CapsuleOral	FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED	82968-011
Pregabalin	Pregabalin 75 mg/1	CapsuleOral	FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED	82968-008
Pregabalin	Pregabalin 100 mg/1	CapsuleOral	FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED	82968-009
Pregabalin	Pregabalin 150 mg/1	CapsuleOral	FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED	82968-010
Pregabalin	Pregabalin 225 mg/1	CapsuleOral	FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED	82968-012
Pregabalin	Pregabalin 300 mg/1	CapsuleOral	FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED	82968-013